HighTide Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	232.39	310.75	608.21	412.34	765.29
Short-Term Investments	93.52	0.18	0.68	428.26	0.5
Trading Asset Securities	176.81	179.77	127.49	-	-
Cash & Short-Term Investments	502.72	490.7	736.38	840.6	765.79
Cash Growth	2.45%	-33.36%	-12.40%	9.77%	-
Other Receivables	0.55	10.9	16.31	2.34	3.64
Receivables	0.55	10.9	16.31	2.34	3.64
Other Current Assets	28.92	11.77	26.07	8.08	5.75
Total Current Assets	532.19	513.37	778.75	851.02	775.18
Property, Plant & Equipment	17.57	23.89	14.98	4.81	3.45
Long-Term Investments	-	21.09	-	-	-
Other Long-Term Assets	1.58	1.58	1.3	-	-
Total Assets	551.34	559.93	795.04	855.82	778.63
Accounts Payable	50.89	51.47	30.51	21.7	6.09
Accrued Expenses	-	5.34	40.68	23.55	14.75
Short-Term Debt	32.5	46.93	3.5	8.15	7
Current Portion of Long-Term Debt	-	-	-	1,260	-
Current Portion of Leases	6.19	5.49	2.47	1.11	0.25
Current Income Taxes Payable	-	0.3	0.38	0.31	0.23
Current Unearned Revenue	-	-	1.4	4.64	-
Other Current Liabilities	8.71	0.42	0.87	0.24	0.21
Total Current Liabilities	98.29	109.95	79.81	1,320	28.53
Long-Term Debt	77.5	9.96	-	-	1,006
Long-Term Leases	10.67	15.53	10.46	1.51	0.9
Long-Term Unearned Revenue	0.21	0.33	1.99	5.12	15.56
Total Liabilities	186.67	135.76	92.26	1,326	1,051
Common Stock	0.41	0.36	0.36	0.03	0.03
Additional Paid-In Capital	-	2,316	2,316	30.61	30.61
Retained Earnings	-	-2,078	-1,696	-757.01	-566.77
Treasury Stock	-0.04	-0.04	-0.04	-0.01	-0
Comprehensive Income & Other	306.65	186.35	83.17	3.12	11.14
Total Common Equity	307.01	424.17	702.77	-723.26	-524.99
Minority Interest	57.66	-	-	-	-
Shareholders' Equity	364.67	424.17	702.77	-470.53	-272.26
Total Liabilities & Equity	551.34	559.93	795.04	855.82	778.63
Total Debt	126.87	77.91	16.43	1,271	1,014
Net Cash (Debt)	375.86	412.8	719.94	-430.19	-248.27
Net Cash Growth	-8.95%	-42.66%	-	-	-
Net Cash Per Share	0.78	0.91	2.77	-1.69	-5.91
Filing Date Shares Outstanding	508.5	514.77	514.77	40.35	42.04
Total Common Shares Outstanding	508.5	514.77	514.77	40.35	42.04
Working Capital	433.9	403.43	698.94	-468.7	746.65
Book Value Per Share	0.60	0.82	1.37	-17.92	-12.49
Tangible Book Value	307.01	424.17	702.77	-723.26	-524.99
Tangible Book Value Per Share	0.60	0.82	1.37	-17.92	-12.49
Machinery	-	4.53	6.09	5.29	5.11
Leasehold Improvements	-	4.44	0.27	0.27	0.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.